EU-IN_VITRO_MEDICAL_DEVICES-ART_3_ANX_1

In Vitro Diagnostic Medical Devices Directive - Hazardous Substances

EU. Hazardous Substances for Purposes of Article 3 & Annex I (Essential Requirements), Directive 98/79/EC on In Vitro Diagnostic Medical Devices, 7 December 1998

This list contains a non-exhaustive inventory of hazardous substances for purposes of essential requirements (Article 3 and Annex I) for general safety, design, manufacture and hazard communication of in vitro diagnostic medical devices. It is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list). Note that Regulation 2017/746/EU on in vitro diagnostic medical devices was published in the EU Official Journal on 5 May 2017. With few exceptions specified in Articles 112 and 113 of this Regulation, Directive 98/79/EC is repealed, and the rules pursuant to 2017/746/EU apply, from 26 May 2022.

Last updated 03 May 2024. Database contains 4821 unique substances/entries.

Filter the list

Showing 101 - 125 of 4,821 results.

Substance Name	EC No.	CAS No.	EU CLP (1272/2008)	EU REACH: List of SVHC
trisodium 3-amino-4-[4-[4-(2-(2-ethenylsulfonylethoxy)ethylamino)-6-fluoro-1,3,5-triazine-2-ylamino]-2-sulfophenylazo]-5-hydroxynaphthalene-2,7-disulfonate	429-240-8	212652-59-0	Eye Dam. 1
trisodium 3-[2-acetylamino-4-[4-chloro-6-[4-(2-sulfonatoxyethylsulfonyl)phenylamino]-1,3,5-triazine-2-ylamino]phenylazo]naphthalene-1,5-disulfonate	427-710-7	215612-56-9	Eye Dam. 1; Skin Sens. 1
trisodium 2-{α[2-hydroxy-3-[4-chloro-6-[4-(2,3-dibromopropionylamino)-2-sulfonatophenylamino]-1,3,5-triazin-2-ylamino]-5-sulfonatophenylazo]-benzylidenehydrazino}-4-sulfonatobenzoate, copper complex BLUE TZ 4312	423-770-3	-	Eye Dam. 1
trisodium 1-hydroxynaphthalene-2-azo-4'(5',5''-dimethylbiphenyl)-4''-azo(4''-phenylsulfonyloxybenzene)-2',2'',4-trisulfonate SCARLET 12 04 262	406-820-9	159317-41-6	Eye Irrit. 2
trisodium (6-anilino-2-(5-nitro-2-oxidophenylazo)-3-sulphonato-1-naphtholato)(4-sulphonato-1,1'-azodi-2,2'naphtholato)chromate(1-) SÄUREBLAU 82 226	402-500-8	104105-46-6	Eye Dam. 1
trisodium (1-(3-carboxylato-2-oxido-5-sulfonatophenylazo)-5-hydroxy-7-sulfonatonaphthalen-2-amido)nickel(II) BROWN 1612969	407-110-1	480445-87-2	Eye Dam. 1; Skin Sens. 1
tris[2-chloro-1-(chloromethyl)ethyl] phosphate	237-159-2	13674-87-8	Carc. 2
tris(tetramethylammonium) 5-hydroxy-1-(4-sulphonatophenyl)-4-(4-sulphonatophenylazo)pyrazole-3-carboxylate LEXMARK YELLOW DYE 415; PRISM YELLOW	406-073-9	131013-81-5	Acute Tox. 3
tris(octadec-9-enylammonium) (trisulfonatophthalocyaninato)copper(II) PIGMENTBLAU 1755	403-210-4	108300-90-9	Eye Dam. 1
tris(nonylphenyl) phosphite	247-759-6	26523-78-4	Skin Sens. 1	yes
Tris(4-nonylphenyl, branched) phosphite show/hide Phenol, p-sec-nonyl-, phosphite EC / List no: - \| CAS no: 106599-06-8 Phenol, p-isononyl-, phosphite (3:1) EC / List no: - \| CAS no: 31631-13-7 Phenol, 4-nonyl-, phosphite (3:1) EC / List no: 608-492-4 \| CAS no: 3050-88-2 Tris(nonylphenyl) phosphite EC / List no: 247-759-6 \| CAS no: 26523-78-4 tris(4-nonylphenyl, branched) phosphite EC / List no: 701-028-2 \| CAS no: -	799-976-5	-		yes
tris(2-methoxyethoxy)vinylsilane; 6-(2-methoxyethoxy)-6-vinyl-2,5,7,10-tetraoxa-6-silaundecane	213-934-0	1067-53-4	Repr. 1B	yes
tris(2-chloroethyl)phosphate	204-118-5	115-96-8	Carc. 2; Repr. 1B; Acute Tox. 4	yes
tris(2-(2-hydroxyethoxy)ethyl)ammonium 3-acetoacetamido-4-methoxybenzenesulfonate ACETOACETYLORTHOSINIC ACID, A6-SALT	403-760-5	68030-79-5	Skin Sens. 1
tris(1-dodecyl-3-methyl-2-phenylbenzimidazolium)hexacyanoferrate	-	7276-58-6	Acute Tox. 4
tripropyltin compounds, with the exception of those specified elsewhere in this Annex	-	-	Acute Tox. 3
tripropylammonium dihydrogenphosphate TRYPROPYLAMMONIUM DIHYDROGENPHOSPHAT	433-700-3	35687-90-2	Acute Tox. 4
triphenyltin compounds, with the exception of those specified elsewhere in this Annex	-	-	Acute Tox. 3
triphenyl(phenylmethyl)phosphonium 1,1,2,2,3,3,4,4,4-nonafluoro-N-methyl-1-butanesulfonamide (1:1)	442-960-7	332350-93-3	Acute Tox. 3; Eye Dam. 1
triphenyl phosphite	202-908-4	101-02-0	Eye Irrit. 2; Skin Irrit. 2
trioctyltin compounds, with the exception of those specified elsewhere in this Annex	-	-	Eye Irrit. 2; STOT SE 3; Skin Irrit. 2
trioctylstannane TZ 02508	413-320-4	869-59-0	STOT RE 1; Skin Irrit. 2
trinickel tetrasulfide	-	12137-12-1	Carc. 1A; STOT RE 1; Skin Sens. 1
trinickel disulfide; nickel subsulfide	234-829-6	12035-72-2	Carc. 1A; Muta. 2; Acute Tox. 3; STOT RE 1; Skin Sens. 1
trinickel boride	234-495-1	12007-02-2	Carc. 1A; STOT RE 1; Skin Sens. 1

Showing 101 - 125 of 4,821 results.

Export search results to:

EU-IN_VITRO_MEDICAL_DEVICES-ART_3_ANX_1

EU-IN_VITRO_MEDICAL_DEVICES-ART_3_ANX_1

In Vitro Diagnostic Medical Devices Directive - Hazardous Substances

EU. Hazardous Substances for Purposes of Article 3 & Annex I (Essential Requirements), Directive 98/79/EC on In Vitro Diagnostic Medical Devices, 7 December 1998

RELEVANT LEGISLATION

Contact EUCLEF Helpdesk

Last updated 03 May 2024. Database contains 4821 unique substances/entries.

Footer Nav Items